"Should all eligible patients with multiple myeloma receive autologous stem-cell transplant as part of initial treatment?"

Philippe Moreau, S Vincent Rajkumar

Research output: Contribution to journalArticle

14 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)677-681
Number of pages5
JournalLeukemia Research
Volume36
Issue number6
DOIs
StatePublished - Jun 2012

Fingerprint

Neoadjuvant Therapy
Autologous Transplantation
Evidence-Based Medicine
Stem Cell Transplantation
Multiple Myeloma
Patient Selection
Stem Cells
Transplants
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

"Should all eligible patients with multiple myeloma receive autologous stem-cell transplant as part of initial treatment?". / Moreau, Philippe; Rajkumar, S Vincent.

In: Leukemia Research, Vol. 36, No. 6, 06.2012, p. 677-681.

Research output: Contribution to journalArticle

@article{27a3d391a196414399eda89d3fe436b7,
title = "{"}Should all eligible patients with multiple myeloma receive autologous stem-cell transplant as part of initial treatment?{"}",
author = "Philippe Moreau and Rajkumar, {S Vincent}",
year = "2012",
month = "6",
doi = "10.1016/j.leukres.2012.02.023",
language = "English (US)",
volume = "36",
pages = "677--681",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - "Should all eligible patients with multiple myeloma receive autologous stem-cell transplant as part of initial treatment?"

AU - Moreau, Philippe

AU - Rajkumar, S Vincent

PY - 2012/6

Y1 - 2012/6

UR - http://www.scopus.com/inward/record.url?scp=84859872850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859872850&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2012.02.023

DO - 10.1016/j.leukres.2012.02.023

M3 - Article

C2 - 22430045

AN - SCOPUS:84859872850

VL - 36

SP - 677

EP - 681

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 6

ER -